CDXS
Price
$3.62
Change
+$0.15 (+4.32%)
Updated
May 10, 6:59 PM EST
81 days until earnings call
PYXS
Price
$4.34
Change
-$0.17 (-3.77%)
Updated
May 10, 6:59 PM EST
One day until earnings call
Ad is loading...

CDXS vs PYXS

Header iconCDXS vs PYXS Comparison
Open Charts CDXS vs PYXSBanner chart's image
Codexis
Price$3.62
Change+$0.15 (+4.32%)
Volume$255.64K
CapitalizationN/A
Pyxis Oncology
Price$4.34
Change-$0.17 (-3.77%)
Volume$127.53K
CapitalizationN/A
View a ticker or compare two or three
CDXS vs PYXS Comparison Chart

Loading...

CDXSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PYXSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CDXS vs. PYXS commentary
May 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a StrongBuy and PYXS is a Buy.

COMPARISON
Comparison
May 13, 2024
Stock price -- (CDXS: $3.62 vs. PYXS: $4.34)
Brand notoriety: CDXS and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 83% vs. PYXS: 35%
Market capitalization -- CDXS: $255.42M vs. PYXS: $255.52M
CDXS [@Biotechnology] is valued at $255.42M. PYXS’s [@Biotechnology] market capitalization is $255.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDXS and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • CDXS’s TA Score: 5 bullish, 5 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а -7.65% price change this week, while PYXS (@Biotechnology) price change was -0.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.77%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +67.78%.

Reported Earning Dates

CDXS is expected to report earnings on Aug 01, 2024.

PYXS is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (-1.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CDXS with price predictions.
OPEN
A.I.dvisor published
a Summary for PYXS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PYXS($256M) and CDXS($255M) have the same market capitalization . PYXS YTD gains are higher at: 141.111 vs. CDXS (18.689).
CDXSPYXSCDXS / PYXS
Capitalization255M256M100%
EBITDAN/AN/A-
Gain YTD18.689141.11113%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSPYXS
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CDXSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PYXSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMNGX20.360.03
+0.15%
MassMutual Mid Cap Growth Y
MMANX2.01N/A
N/A
MassMutual Growth Opps R3
TOTFX11.48N/A
N/A
Transamerica Mid Cap Value Opps R4
HRIIX10.64-0.04
-0.37%
Hood River International Opportunity Inv
TGWFX12.06-0.10
-0.82%
Transamerica Large Growth R4

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with ABCL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+4.32%
ABCL - CDXS
47%
Loosely correlated
-3.04%
DNA - CDXS
46%
Loosely correlated
-17.29%
DNLI - CDXS
45%
Loosely correlated
-1.93%
RCKT - CDXS
45%
Loosely correlated
-2.61%
NTLA - CDXS
44%
Loosely correlated
-1.61%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with CTMX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-3.77%
CTMX - PYXS
39%
Loosely correlated
-2.94%
DNLI - PYXS
38%
Loosely correlated
-1.93%
VKTX - PYXS
35%
Loosely correlated
-8.18%
CDXS - PYXS
35%
Loosely correlated
+4.32%
JANX - PYXS
35%
Loosely correlated
-5.81%
More